Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
1.83 | 0.50 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
15.07 | 2.36 | 0.99% |
Piramal Enterprises Limited (PEL) is engaged in the business of pharmaceuticals, including research and development, financial services and information management through its subsidiaries.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has increased by 2.18%
4 days ago•Economic Times
2 weeks ago•Moneycontrol
2 weeks ago•Bloomberg Quint
3 weeks ago•Financial Express
3 weeks ago•Economic Times
3 weeks ago•Bloomberg Quint
3 weeks ago•Moneycontrol
3 weeks ago•The Hindu Businessline
3 weeks ago•The Hindu
3 weeks ago•Economic Times
Final • Div/Share: ₹ 33
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant